Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents

Miguel Ruão1 Department of Ophthalmology, Centro Hospitalar Entre Douro e Vouga, Santa Maria da Feira, PortugalCorrespondence[email protected]

María Andreu-Fenoll2 Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Valencia, spain

Rosa Dolz-Marco2 Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Valencia, spain

Roberto Gallego-Pinazo2 Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, Valencia, spain

Pages 299-302 | Published online: 01 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LimaLHZweifelSAEngelbertMEvaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapyRetina20092991213121719934815
PubMed Web of Science ®Google Scholar
RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
PubMed Web of Science ®Google Scholar
WolfSBalciunieneVJLaganovskaGRADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopiaOphthalmology20141213682692.e224326106
PubMed Web of Science ®Google Scholar
BakriSJRiscoMEdwardsAOPulidoJSBilateral simultaneous intravitreal injections in the office settingAm J Ophthalmol200914816669.e119403114
PubMed Web of Science ®Google Scholar
Green-SimmsAEEkdawiNSBakriSJSurvey of intravitreal injection techniques among retinal specialists in the United StatesAm J Ophthalmol2011151232933221168821
PubMed Web of Science ®Google Scholar
Abu-YaghiNEShokryANAbu-SbeitRHBilateral same-session intravitreal injections of anti-vascular endothelial growth factorsInt J Ophthalmol2014761017102125540758
PubMed Web of Science ®Google Scholar
ChaoDLGregoriNZKhandjiJGoldhardtRSafety of bilateral intravitreal injections delivered in a teaching institutionExpert Opin Drug Deliv201411799199324815986
PubMed Web of Science ®Google Scholar
DavisRPScheflerACMurrayTGConcomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degenerationClin Ophthalmol2010470370720689785
PubMedGoogle Scholar
MahajanVBElkinsKARussellSRBilateral intravitreal injection of antivascular endothelial growth factor therapyRetina2011311313521187731
PubMed Web of Science ®Google Scholar
WooSJHanJMAhnJBilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillanceRetina201232466767122307220
PubMed Web of Science ®Google Scholar
DiagoTMcCannelCABakriSJPulidoJSEdwardsAOPachJMInfectious endophthalmitis after intravitreal injection of antiangiogenic agentsRetina200929560160519357558
PubMed Web of Science ®Google Scholar
FintakDRShahGKBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina200828101395139918827737
PubMed Web of Science ®Google Scholar
McCannelCAMeta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategiesRetina201131465466121330939
PubMed Web of Science ®Google Scholar
MartinDFMaguireMGYingGSGrunwaldJEFineSLJaffeGJRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
PubMed Web of Science ®Google Scholar
MeraniRHunyorAPEndophthalmitis following intravitreal antivascular endothelial growth factor (VEGF) injection: a comprehensive reviewInt J Retina Vitreous20151927847602
PubMedGoogle Scholar
FenollMAARCSTERILE: A COST-EFFECTIVE LUXURYRev Enferm2015385812 Spanish
PubMed Web of Science ®Google Scholar
WangDChoiKSLeeSJSerum concentration of vascular endothelial growth factor after bilateral intravitreal injection of bevacizumabKorean J Ophthalmol2014281323824505199
PubMedGoogle Scholar
DavidovicSPNikolicSVCuricNJChanges of serum VEGF concentration after intravitreal injection of Avastin in treatment of diabetic retinopathyEur J Ophthalmol201222579279822344470
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date